Replies to post #86684 on Biotech Values

[AlpineBV_Miller]

So what would you have liked them to measure?

Measuring HDL/LDL for a CETP inhibitor is not useful for determining power and setting up trial design, which is the whole point of a Phase II program. Morbidity and mortality are the proper endpoints.